Aardvark Therapeutics, Inc. (AARD)
4.54
+0.03
(+0.67%)
USD |
NASDAQ |
May 22, 16:00
4.51
-0.03
(-0.66%)
After-Hours: 20:00
Aardvark Therapeutics Shareholders Equity (Quarterly) : 86.99M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alumis, Inc. | 567.02M |
| SIGA Technologies, Inc. | 151.62M |
| Zoetis, Inc. | 3.233B |
| ANI Pharmaceuticals, Inc. | 562.30M |
| Corcept Therapeutics, Inc. | 637.99M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 98.59M |
| Total Liabilities (Quarterly) | 11.60M |
| Debt to Equity Ratio | 0.0039 |
| Current Ratio | 8.064 |
| Net Debt Paydown Yield | 0.11% |